Alembic Pharma gets USFDA nod for Acetazolamide extended release capsules Farhat Nasim21 Feb 2019 9:45 AM ISTAcetazolamide extended-release capsule is therapeutically equivalent to the reference listed drug, Diamox Sequels, 500 mg, of Teva Branded...
Alembic Pharma gets USFDA nod for Olopatadine Hydrochloride ophthalmic solution Farhat Nasim17 Feb 2019 9:30 AM ISTThe company has received approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Olopatadine...
NPPA fixes retail price of Emcure pharma's HIV drug Meghna A Singhania17 Feb 2019 9:30 AM ISTNew Delhi: Through a recent notice, the drug price regulator National Pharmaceutical Pricing Authority (NPPA) has fixed the retail price of Emcure...
NPPA fixes retail price of 29 drug formulations including BP, Cholesterol, pain medications; Details Farhat Nasim30 Jan 2019 11:32 AM ISTThe NPPA order is likely to affect various drug majors including Lupin, Sun Pharmaceuticals, GlaxoSmithKline and Cadila Pharmaceuticals. New Delhi:...
Alembic Pharma gets USFDA nod for Olopatadine Hydrochloride ophthalmic solution Medical Dialogues Bureau10 Dec 2018 9:15 AM ISTNew Delhi: Drug firm Alembic Pharma on Monday said it has received approval from the US health regulator for Olopatadine Hydrochloride ophthalmic...
Alembic Pharma Q2 net rises over 1 percent to Rs 121 crore Ruby Khatun Khatun9 Nov 2017 10:16 AM ISTNew Delhi: Alembic Pharmaceuticals reported a 1.44 percent increase in consolidated net profit at Rs 121.56 crore for the second quarter ended...
